HIK - HIKMA PHARMACEUTICALS - Share Chat

Hikma Pharmaceuticals plc is a FTSE 100 global pharmaceutical company, headquartered in the UK, with a focus on developing, manufacturing, and marketing a broad range of generic, branded, and injectable medicines. Its three core segments – Injectables, Generics, and Branded – serve diverse markets, with a strong presence in the US, MENA region, and Europe.

The Injectables division is a key revenue driver, particularly in the US, where it is a leading supplier of generic sterile injectable medications, often benefiting from its extensive portfolio and ability to address supply chain needs. The Generics segment primarily operates in the US, offering a range of oral and other dosage forms. Its Branded segment serves the Middle East and North Africa with a portfolio of patented and in-licensed products, leveraging its long-standing regional presence. Hikma is known for its robust manufacturing capabilities, commitment to quality, and strategic investments in R&D and partnerships to expand its product pipeline and market reach.